Alignment Healthcare (NASDAQ:ALHC) Posts Earnings Results, Misses Estimates By $0.01 EPS

Alignment Healthcare (NASDAQ:ALHC) released its earnings results on Thursday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01), Briefing.com reports. The firm had revenue of $628.60 million for the quarter, compared to analyst estimates of $599.75 million. Alignment Healthcare had a negative net margin of 8.12% and a negative return on equity of 75.64%. The business’s revenue for the quarter was up 43.1% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.20) EPS.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $6.63 on Friday. Alignment Healthcare has a twelve month low of $4.46 and a twelve month high of $9.20. The stock’s 50 day moving average is $5.11 and its 200-day moving average is $6.55. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 1.02. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of -8.39 and a beta of 1.23.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Piper Sandler reissued a “neutral” rating and set a $6.00 target price (down previously from $12.00) on shares of Alignment Healthcare in a research note on Wednesday, March 6th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research report on Wednesday, March 6th. UBS Group cut their target price on Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating on the stock in a research report on Wednesday, February 28th. Raymond James lifted their target price on Alignment Healthcare from $10.00 to $12.00 and gave the stock a “strong-buy” rating in a report on Tuesday, January 9th. Finally, Stifel Nicolaus cut their price target on Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating on the stock in a report on Tuesday, April 23rd. One research analyst has rated the stock with a sell rating, four have given a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $8.83.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, CFO Robert Thomas Freeman sold 11,858 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $4.89, for a total transaction of $57,985.62. Following the transaction, the chief financial officer now owns 898,228 shares in the company, valued at $4,392,334.92. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, insider Dawn Christine Maroney sold 23,000 shares of Alignment Healthcare stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $5.44, for a total transaction of $125,120.00. Following the transaction, the insider now owns 1,830,008 shares of the company’s stock, valued at $9,955,243.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Robert Thomas Freeman sold 11,858 shares of the company’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $4.89, for a total value of $57,985.62. Following the sale, the chief financial officer now owns 898,228 shares of the company’s stock, valued at approximately $4,392,334.92. The disclosure for this sale can be found here. In the last 90 days, insiders sold 90,213 shares of company stock valued at $460,587. 6.30% of the stock is owned by company insiders.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.